Stocktoria
Twist Bioscience Corp TWST
Twist Bioscience Corp financials (annual)
Bars are annual figures from 2018 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $376.6M | $313.0M | $245.1M | $203.6M | $132.3M | $90.1M | $54.4M | $25.4M |
| R&D expense | $80.3M | $90.9M | $106.9M | $120.3M | $69.1M | $43.0M | $35.7M | $20.3M |
| SG&A expense | $247.0M | $218.4M | $189.7M | $212.9M | $135.9M | $103.3M | $80.1M | $43.5M |
| Operating income | -$136.3M | -$220.8M | -$217.2M | -$234.8M | -$152.7M | -$140.1M | -$108.8M | -$70.6M |
| Interest expense | — | — | $5,000 | $80,000 | $367,000 | $787,000 | $1.3M | $1.3M |
| Income tax | $719,000 | $560,000 | $1.2M | -$10.4M | -$1.9M | $382,000 | $292,000 | $242,000 |
| Net income | -$77.7M | -$208.7M | -$204.6M | -$217.9M | -$152.1M | -$139.9M | -$107.7M | -$71.2M |
| EPS (diluted) | $-1.30 | $-3.60 | $-3.60 | $-4.04 | $-3.15 | $-3.57 | — | — |
| Operating cash flow | -$47.6M | -$64.1M | -$142.5M | -$124.4M | -$112.2M | -$142.3M | -$87.9M | -$66.2M |
| Free cash flow | -$75.6M | -$69.2M | -$170.3M | -$226.2M | -$139.3M | -$152.1M | -$102.7M | -$69.9M |
| Cash & equivalents | $183.0M | $226.3M | $286.5M | $378.7M | $465.8M | $93.7M | $46.7M | $80.8M |
| Inventory | $28.3M | $24.1M | $32.1M | $39.3M | $31.8M | $12.3M | $7.3M | $6.0M |
| Total assets | $641.9M | $614.3M | $776.4M | $961.4M | $702.1M | $398.9M | $187.0M | $115.8M |
| Total liabilities | $168.9M | $141.6M | $153.0M | $172.0M | $121.3M | $62.6M | $34.9M | $26.7M |
| Shareholders' equity | $473.0M | $472.7M | $623.4M | $789.4M | $580.8M | $336.3M | $152.1M | -$201.4M |
Growth · year-over-year · Revenue CAGR 47%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue growth | +20.3% | +27.7% | +20.4% | +53.8% | +46.9% | +65.7% | +113.9% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-09-30. Facts plus Stocktoria's own computed scores — not investment advice.